A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new ...
(HSCT) following U.S. FDA approval of Tregzi, a first-of-its-kind, personalized cell therapy. Previously known as Orca-T, Tregzi is indicated for use in matched-donor HSCT with myeloablative ...
The SUBITO trial, presented by Rianne L Seefat and colleagues in The Lancet Oncology,1 revisits the long-standing debate ...
Excerpts from recent editorials in the United States and abroad: ___ June 27 The Washington Post on the federal government's real estate problem stifling local economies The federal government is the ...
Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...
Inside the cleaners that promote a healthier home beyond just removing dirt and grime, exploring safer ingredients, improved ...
Explore the best cleaners that go beyond surface-level shine—supporting a healthier home environment with safer, non-toxic ...
Explore the best cleaners that go beyond surface-level shine—supporting a healthier home environment with safer, non-toxic ...
The FDA has approved sacituzumab govitecan-hziy as first-line therapy for adults with unresectable locally advanced or ...
Donald Trump’s vision was to paint the Lincoln Memorial Reflecting Pool a darker shade of “American flag blue” to celebrate the country’s 250th birthday. But this week, ...
A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results